Use of interferon-gamma release assays to calculate the annual risk of tuberculosis infection

Nuria Díez, Empar Giner, Irene Latorre, Alícia Lacoma, Francisco Javier Roig, Irene Mialdea, Jessica Díaz, Mar Serra-Vidal, Amparo Escribano, Jose Domínguez

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

5 Cites (Scopus)

Resum

Copyright © 2014 by Wolters Kluwer Health, Inc. All rights reserved. The objective was to assess the annual risk of tuberculosis infection by means of tuberculin skin testing (TST) in children, evaluating whether QuantiFERON-TB Gold In-Tube (QFN-G-IT) could improve the accuracy. On the basis of the positive TST results, the global annual incidence was estimated at 0.78%, with an increase in the prevalence from 0.64% to 1.68% in 2 years. However, QFN-G-IT was only positive in 6 of the 25 children with positive TST. The confirmation of the positive TST results by QFN-G-IT provided more accurate annual incidence estimation.
Idioma originalAnglès
Pàgines (de-a)219-221
RevistaJournal of Pediatric Infectious Diseases
Volum34
Número2
DOIs
Estat de la publicacióPublicada - 1 de gen. 2015

Fingerprint

Navegar pels temes de recerca de 'Use of interferon-gamma release assays to calculate the annual risk of tuberculosis infection'. Junts formen un fingerprint únic.

Com citar-ho